Novo Nordisk A/S Common Stock (NVO)

Financing Cash Flow

-kr 19.13B

Quarterly · Period ending: · DKK

NVO logo

NVO Financing Cash Flow

Latest reported-kr 19.13B DKK
NVO Quarterly Cash from Financing · DKK (-kr 1.50B → -kr 19.13B)
High-resolution chart · PNG

NVO financing cash flow history

Quarterly · DKK. Dates are reporting period ends; fiscal years can differ from calendar years.

Novo Nordisk A/S Common Stock Financing Cash Flow — Quarterly (DKK)
Period endingFinancing Cash Flow (DKK)
-19,132,000,000
-17,433,000,000
29,467,000,000
-17,096,000,000
-46,230,000,000
5,451,000,000
36,835,000,000
-18,401,000,000
16,683,000,000
-26,382,000,000
-10,116,000,000
-19,832,000,000
-12,589,000,000
-20,621,000,000
-7,668,000,000
-14,563,000,000
-10,431,000,000
-19,135,000,000
4,549,000,000
-11,731,000,000
-3,836,000,000
-14,475,000,000
-360,000,000
-10,694,000,000
-7,681,000,000
-13,509,000,000
-5,201,000,000
-10,012,000,000
-6,746,000,000
-13,525,000,000
-4,152,000,000
-10,809,000,000
-5,423,000,000
-14,137,000,000
-4,602,000,000
-11,634,000,000
-5,728,000,000
-13,725,000,000
-4,095,000,000
-11,199,000,000
-6,419,000,000
-17,174,000,000
-4,447,000,000
-4,990,000,000
-6,300,000,000
-14,364,000,000
-3,872,000,000
-3,954,000,000
-5,531,000,000
-13,176,000,000
-3,019,000,000
-2,832,000,000
-6,929,000,000
-10,859,000,000
-1,708,000,000
-1,981,000,000
-5,881,000,000
-10,570,000,000
-2,959,000,000
-4,870,000,000
-1,985,000,000
-6,988,000,000
-1,499,000,000
-4,171,000,000
-2,010,000,000
-5,540,000,000
-1,530,000,000
-2,649,000,000
-1,378,000,000
-4,488,000,000
-1,218,162,450
-1,932,148,550
-870,540,350
-3,366,393,850
-2,099,957,200
-2,619,246,700
-13,717,660
-2,109,610,440
83,089,030
-2,377,427,030
-179,535,550
-2,283,931,650
-269,417,840
-949,657,200
-1,402,220,250
-1,810,402,650
-637,182,870
-636,850,970
-701,336,370
-1,498,413,520
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.